137th Meeting of the National Advisory Council on Drug Abuse
Virtual Meeting – February 9, 2021
Closed Session
This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).
10:45 a.m. – 12:30 p.m.
10:45 a.m. | Call to Order Nora Volkow, M.D. Director, NIDA Review of Policy and Procedures Susan Weiss, Ph.D. Executive Secretary National Advisory Council on Drug Abuse Director, Division of Extramural Research, NIDA |
11:00 a.m. |
Council Review of Grant Applications Division of Therapeutics and Medical Consequences (DTMC) |
Brief Break | |
12:00 p.m. | Report to Council from the BSC Amy Newman, Ph.D., Director, NIDA IRP Regina Carelli, Ph.D., BSC Chair |
12:30 p.m. | Break |
Videocast:
Members of the public who may wish to express views regarding any items discussed during this meeting may do so by writing Dr. Gillian Acca, within ten days of the meeting. Any written statements by members of the public will receive careful consideration.
Open Session
1:15 - 4:30 p.m.
1:15 p.m. | Welcome and Opening Remarks Nora Volkow, M.D. Director, NIDA |
1:30 p.m. | Director's Report Nora Volkow, M.D. Director, NIDA |
2:20 p.m. | Discussion Council Members |
2:40 p.m. | Standardized Unit of Measure for Cannabis Research Susan Weiss, Ph.D. Director, Division of Extramural Research Emily Einstein, Ph.D. Chief, Science Policy Branch, OSPC |
3:10 p.m. | NIDA Meetings Report
|
4:10 p.m. | Concept Clearances
|
4:20 p.m. | Public Comments |
4:30 p.m. | Adjourn |